BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10227005)

  • 1. Differential diagnosis of peri- and postmenopausal ovarian cysts.
    Reimer T; Gerber B; Müller H; Jeschke U; Krause A; Friese K
    Maturitas; 1999 Jan; 31(2):123-32. PubMed ID: 10227005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol, gonadotropins, and tumor markers in ovarian cyst fluid.
    Reimer T; Gerber B; Kunkel S; Luettich K
    Acta Obstet Gynecol Scand; 1997 May; 76(5):478-83. PubMed ID: 9197453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
    Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
    Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian cysts: strategy and prognosis].
    Querleu D; Parmentier D; Chevallier L
    Contracept Fertil Sex; 1993 Feb; 21(2):167-72. PubMed ID: 7951609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor].
    Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N
    Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of cyst puncture in the differential diagnosis of benign ovarian tumours.
    Vercellini P; Oldani S; Felicetta I; Bramante T; Rognoni MT; Crosignani PG
    Hum Reprod; 1995 Jun; 10(6):1465-9. PubMed ID: 7593516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA-125 is a good predictor of benign disease in patients with postmenopausal ovarian cysts.
    Dikensoy E; Balat O; Ugur MG; Ozkur A; Erkilic S
    Eur J Gynaecol Oncol; 2007; 28(1):45-7. PubMed ID: 17375706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of unilocular or multilocular cysts more than 5 centimeters in postmenopausal women.
    Guraslan H; Dogan K
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():40-3. PubMed ID: 27240260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian incidentaloma.
    Solnik MJ; Alexander C
    Best Pract Res Clin Endocrinol Metab; 2012 Feb; 26(1):105-16. PubMed ID: 22305456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.
    Rzepka-Górska I; Chudecka-Głaz A; Kosmowska B
    Endocr Relat Cancer; 2004 Jun; 11(2):315-21. PubMed ID: 15163306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic postmenopausal simple ovarian cyst.
    Oyelese Y; Kueck AS; Barter JF; Zalud I
    Obstet Gynecol Surv; 2002 Dec; 57(12):803-9. PubMed ID: 12493982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracystic evaluation of tumor markers in benign and malignant ovarian pathology.
    Cherchi PL; Capobianco G; Ambrosini G; Fadda GM; Piga MD; Ruiu G; Fattorini F; Dessole S
    Eur J Gynaecol Oncol; 2002; 23(2):163-5. PubMed ID: 12013118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The levels of selected hormones in serum and ovarian cyst fluid in girls and young women].
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B; Głaz C
    Ginekol Pol; 1999 May; 70(5):236-41. PubMed ID: 10462955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.